Erik Penser

Hansa Biopharma to host conference call to provide interim results for first half 2021 and Business Update

Retrieved on: 
Thursday, July 1, 2021
Geography of Sweden, Municipalities of Sweden, Erik Penser, Stockbrokers, Stockholm, Handelsbanken

LUND, Sweden, July 1, 2021 /PRNewswire/ -- Hansa Biopharma AB (Nasdaq Stockholm: HNSA) will publish its interim report for January-June 2021 at 8:00 CET on July 15, 2021.

Key Points: 
  • LUND, Sweden, July 1, 2021 /PRNewswire/ -- Hansa Biopharma AB (Nasdaq Stockholm: HNSA) will publish its interim report for January-June 2021 at 8:00 CET on July 15, 2021.
  • All interested parties are invited to participate in a telephone conference, which will include a presentation of the interim results and a business update, on the same date at 14:00 CET/8:00am EST.
  • The event will be hosted by Hansa Biopharma's CEO, Sren Tulstrup, and CFO, Donato Spota, and the presentation will be held in English.
  • Link to presentation
    To participate in the telephone conference, please use the dial-in details provided below:
    July 15, 2021 William Blair Biotech Focus Conference, 2021 (virtual)
    Aug 25, 2021 Handelsbanken Life Science Innovation Seminar, Stockholm
    Aug 31, 2021 Presentation at Penser Access, Skne
    Nov 25, 2021 Erik Penser Banks Bolagsdag, Stockholm or virtual

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT MAY 2021

Retrieved on: 
Thursday, June 3, 2021
Erik Penser, Stockbrokers, Aktiebolag, Bergheim, Economy, Articles, Sweden

Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25700, zinzino.com

Key Points: 
  • Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25700, zinzino.com
    Pictures for publication free of charge:
    Marcus Tollbom +46 (0) 70 190 03 12, [email protected]
    Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: [email protected]
    Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse.
  • The information was provided by the above contact person for publication at 13:00 the 3rd of June 2021.

Analysis of Scandinavian ChemoTech AB published by Erik Penser Bank now available in English

Retrieved on: 
Friday, May 14, 2021
Geography of Sweden, Erik Penser, Stockbrokers, Municipalities of Sweden, Stockholm

b"STOCKHOLM, May 14, 2021 /PRNewswire/ -- In accordance with the newsletter that was published the 5th of January 2021, Erik Penser Bank has now begun the implementation of a number of commissioned analyses, the first of which has been published and is available on ChemoTech's website in English:\n"

Key Points: 
  • b"STOCKHOLM, May 14, 2021 /PRNewswire/ -- In accordance with the newsletter that was published the 5th of January 2021, Erik Penser Bank has now begun the implementation of a number of commissioned analyses, the first of which has been published and is available on ChemoTech's website in English:\n"

ZINZINO AB (PUBL): A new signature BalanceOil from the pioneers of test-based nutrition

Retrieved on: 
Thursday, April 15, 2021
World Geographical Scheme for Recording Plant Distributions, Plants, Mediterranean cuisine, Koroneiki, Olive, Lemon, Erik Penser

b"STOCKHOLM, April 15, 2021 /PRNewswire/ -- The global, Scandinavian health and wellness brand is taking the next step in its ambition to shape the future of nutrition with test-based, scientifically proven supplements.

Key Points: 
  • b"STOCKHOLM, April 15, 2021 /PRNewswire/ -- The global, Scandinavian health and wellness brand is taking the next step in its ambition to shape the future of nutrition with test-based, scientifically proven supplements.
  • The launch of R.E.V.O.O was an immediate success, made with exclusive Koroneiki olives, using ancient principals' re-thought, redesigned and rebuilt.
  • What better way to bring this exceptional high phenolic extra virgin olive oil to even more use than to put it in our bestseller BalanceOil with natural orange, lemon and mint flavor!\nThe unique, scientifically certified formulation in BalanceOil+ Premium offers up to 4 times more antioxidants.
  • Learn more about the entire Zinzino product range and how to order the products at Zinzino.com\nPictures for publication free of charge:\nMarcus Tollbom +46 (0) 70 190 03 12, [email protected]\nCertified Adviser:Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: [email protected]\n"

OncoZenge secures approximately SEK 70 million in financing ahead of spin-off and separate listing

Retrieved on: 
Monday, November 16, 2020
Financial markets, Erik Penser, Stockbrokers, SEK, Moberg, Stock dilution

The capital requirement to finance the Phase 3 study, expected to begin in early 2022, and the Company's continuing operations is approximately SEK 60 million.

Key Points: 
  • The capital requirement to finance the Phase 3 study, expected to begin in early 2022, and the Company's continuing operations is approximately SEK 60 million.
  • To secure its initial capital requirements, OncoZenge has received binding commitments for a directed issue of approximately SEK 10 million ("Directed Issue").
  • Based on the subscription price in the Directed Issue, the value of OncoZenge before the Directed Issue is approximately SEK 50 million, resulting in a dilution of approximately 16.7 percent from the Directed Issue.
  • Erik Penser Bank is serving as financial advisor and Gernandt & Danielsson Advokatbyr is serving as legal advisor to Moberg Pharma and OncoZenge in connection with the distribution, financing and listing of OncoZenge.

INVISIO Appoints Market Maker

Retrieved on: 
Monday, April 1, 2019
Economy, Financial markets, Finance, Money, Erik Penser, Stockbrokers, Market maker, Short, European Union

STOCKHOLM, April 1, 2019 /PRNewswire/ --INVISIO has today entered into an agreement with Erik Penser Bank AB that Erik Penser Bank shall act as market maker in the company's share.

Key Points: 
  • STOCKHOLM, April 1, 2019 /PRNewswire/ --INVISIO has today entered into an agreement with Erik Penser Bank AB that Erik Penser Bank shall act as market maker in the company's share.
  • In short, the agreement means that the market maker places bid and ask prices for INVISIO's share and ensures a low spread between buying and selling prices.
  • This information is information that INVISIO Communications AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation.
  • INVISIO develops and sells advanced communication systems with hearing protection that enable professionals in noisy and mission critical environments to communicate and operate effectively.

INVISIO Appoints Market Maker

Retrieved on: 
Monday, April 1, 2019
Economy, Financial markets, Finance, Money, Erik Penser, Stockbrokers, Market maker, Short, European Union

STOCKHOLM, April 1, 2019 /PRNewswire/ --INVISIO has today entered into an agreement with Erik Penser Bank AB that Erik Penser Bank shall act as market maker in the company's share.

Key Points: 
  • STOCKHOLM, April 1, 2019 /PRNewswire/ --INVISIO has today entered into an agreement with Erik Penser Bank AB that Erik Penser Bank shall act as market maker in the company's share.
  • In short, the agreement means that the market maker places bid and ask prices for INVISIO's share and ensures a low spread between buying and selling prices.
  • This information is information that INVISIO Communications AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation.
  • INVISIO develops and sells advanced communication systems with hearing protection that enable professionals in noisy and mission critical environments to communicate and operate effectively.